ALIGN TECHNOLOGY INC

NASDAQ: ALGN (Align Technology, Inc.)

Kemas kini terakhir: 09 Feb, 11:09PM

192.50

4.90 (2.61%)

Penutupan Terdahulu 187.60
Buka 188.00
Jumlah Dagangan 1,871,947
Purata Dagangan (3B) 1,273,591
Modal Pasaran 13,953,626,112
Harga / Pendapatan (P/E TTM) 34.01
Harga / Pendapatan (P/E Ke hadapan) 17.09
Harga / Jualan (P/S) 3.36
Harga / Buku (P/B) 3.31
Julat 52 Minggu
122.00 (-36%) — 212.23 (10%)
Tarikh Pendapatan 29 Apr 2026
Margin Keuntungan 10.29%
Margin Operasi (TTM) 14.02%
EPS Cair (TTM) 5.50
Pertumbuhan Hasil Suku Tahunan (YOY) -1.80%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -11.20%
Jumlah Hutang/Ekuiti (D/E MRQ) 3.12%
Nisbah Semasa (MRQ) 1.21
Aliran Tunai Operasi (OCF TTM) 762.24 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 630.04 M
Pulangan Atas Aset (ROA TTM) 6.72%
Pulangan Atas Ekuiti (ROE TTM) 10.84%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Menurun
Medical Instruments & Supplies (Global) Bercampur Menurun
Stok Align Technology, Inc. Menaik Menurun

AISkor Stockmoo

0.3
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga -4.5
Purata Bergerak Teknikal 0.0
Osilator Teknikal 4.0
Purata 0.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
ALGN 14 B - 34.01 3.31
HOLX 17 B - 30.18 3.19
COO 16 B - 43.69 1.95
ISRG 173 B - 61.73 9.68
MMSI 5 B - 44.30 3.17
LMAT 2 B 0.91% 37.84 5.23

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Mid Core
% Dimiliki oleh Orang Dalam 6.68%
% Dimiliki oleh Institusi 94.17%
Julat 52 Minggu
122.00 (-36%) — 212.23 (10%)
Julat Harga Sasaran
169.00 (-12%) — 220.00 (14%)
Tinggi 220.00 (Piper Sandler, 14.29%) Beli
Median 200.00 (3.90%)
Rendah 169.00 (Morgan Stanley, -12.21%) Pegang
Purata 194.89 (1.24%)
Jumlah 6 Beli, 3 Pegang
Harga Purata @ Panggilan 174.53
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
HSBC 09 Feb 2026 200.00 (3.90%) Beli 192.50
Evercore ISI Group 05 Feb 2026 200.00 (3.90%) Beli 175.62
Morgan Stanley 05 Feb 2026 169.00 (-12.21%) Pegang 175.62
Piper Sandler 05 Feb 2026 220.00 (14.29%) Beli 175.62
Stifel 05 Feb 2026 210.00 (9.09%) Beli 175.62
UBS 05 Feb 2026 185.00 (-3.90%) Pegang 175.62
Wells Fargo 05 Feb 2026 200.00 (3.90%) Beli 175.62
Mizuho 20 Jan 2026 200.00 (3.90%) Beli 165.55
Barclays 09 Dec 2025 170.00 (-11.69%) Pegang 159.00

Tiada data dalam julat masa ini.

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda